Curated News
By: NewsRamp Editorial Staff
May 21, 2025
Quantum BioPharma Partners with BitGo Trust for Secure Digital Asset Custody
TLDR
- Quantum BioPharma partners with BitGo Trust for secure custody of digital assets, enhancing market advantage.
- BitGo Trust provides secure custody through multi-signature wallets and cold storage, ensuring compliance and protection of Quantum's assets.
- Quantum BioPharma's partnership with BitGo Trust ensures secure management of assets, contributing to a safer digital asset environment for all.
- Quantum BioPharma's innovative approach to secure custody with BitGo Trust highlights the evolving landscape of digital asset protection in biopharmaceutical industry.
Impact - Why it Matters
This news highlights the increasing importance of secure digital asset management in the biopharmaceutical industry. Investors and stakeholders should take note of Quantum BioPharma's proactive approach to protecting its holdings and ensuring compliance, signaling a commitment to long-term growth and stability.
Summary
Quantum BioPharma (NASDAQ: QNTM) has partnered with BitGo Trust Company to provide secure custody for its Bitcoin, Solana, XRP, and DOGE holdings, emphasizing security and compliance. CEO Zeeshan Saeed highlighted the importance of the partnership in strengthening Quantum's digital asset strategy while maintaining public company standards.
Quantum BioPharma, a biopharmaceutical company focused on innovative assets for neurodegenerative and metabolic disorders, is dedicated to the development of Lucid-MS, a compound targeting multiple sclerosis. Through its subsidiary, Quantum retains ownership of Celly Nutrition and strategic investments, further expanding its portfolio and market presence.
Source Statement
This curated news summary relied on this press release disributed by InvestorBrandNetwork (IBN). Read the source press release here, Quantum BioPharma Partners with BitGo Trust for Secure Digital Asset Custody
